SynuSight Biotech, ABLi Therapeutics, and XingImaging have formed a strategic collaboration aimed at integrating alpha-synuclein PET imaging into clinical trials for evaluating the efficacy...
An international study has revealed that wearable technology can potentially identify Parkinson’s disease (PD) up to nine years before clinical diagnosis. This groundbreaking research...